SCHEMBL931895

SCHEMBL931895

COc1ncc(C(=N)c2cccc(Br)c2)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1S P09871 1/20 0.41
TSHR P16473 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
ALDH1A1 P00352 2/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
PARP1 P09874 1/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931729 0.79 C1S (0.46) C1STSHRNPSR1NPC1RAB9A
SCHEMBL933081 0.77 ALOX15 (0.47) C1SNPSR1NPC1RAB9AALDH1A1
SCHEMBL931923 0.72 C1S (0.49) C1SNPSR1NPC1RAB9AALDH1A1
SCHEMBL3463154 0.72 HDAC1 (0.36)
SCHEMBL18540642 0.72 PRSS1 (0.49) C1SNPC1RAB9APARP1KMT2A
SCHEMBL932093 0.70 C1S (0.50) C1STSHRNPSR1NPC1RAB9A
SCHEMBL27018623 0.69 C1S (0.57) C1STSHRNPSR1NPC1RAB9A
SCHEMBL323430 0.69 AAK1 (0.38) NPSR1ALDH1A1KMT2AKDM4EMAPK1
SCHEMBL931617 0.69 C1S (0.41) C1STSHRNPSR1NPC1RAB9A
Hydrochloric Acid SCHEMBL1784330 0.68 C1S (0.55) C1STSHRNPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed